The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Investigating Women's Preference for Sildenafil or Tadalafil Use by Their Partners with Erectile Dysfunction: The Partners' Preference Study
Abstract
Introduction: Several preference studies comparing a short-acting with a longer-acting phosphodiesterase type 5 inhibitor have been conducted in men. Most men in those studies preferred tadalafil rather than sildenafil, and recent post hoc analysis of one study described several factors associated with men's treatment preference. No prospective studies have investigated the woman partners' preferences. Aim: To investigate the treatment preference of women who were partners of men using oral medications for erectile dysfunction (ED) in a single-center open-label crossover study. Methods: One hundred heterosexual couples in stable relationships, with male partners having ED based on the erectile function subscale of the International Index of Erectile Function, were randomly assigned to receive sildenafil or tadalafil for a 12-week phase, followed by another 12-week period using the alternate drug. Male and female participants completed sexual event diaries during both study phases, and the female participants were interviewed at baseline, midpoint, and end of study. Main Outcome Measures: Primary outcome data were the women's final interviews during which they were asked which drug they preferred and their reasons for that preference. Results: A total of 79.2% of the women preferred their partners' use of tadalafil, while 15.6% preferred sildenafil. Preference was not affected by age or treatment order randomization. Women preferring tadalafil reported feeling more relaxed, experiencing less pressure, and enjoying a more natural or spontaneous sexual experience as reasons for their choice. Mean number of tablets used, events recorded, events per week, and days between events were not significantly different during each study phase. Conclusion: Women's preferences were similar to men when using these two drugs. While the women's reasons for preferring tadalafil emphasized relaxed, satisfying, longer-lasting sexual experiences, those preferring sildenafil focused on satisfaction and drug effectiveness for their partner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Tadalafil was preferred by the female partner in 79.2%, while 15.6% preferred sildenafil.”
From Tadalafil in the treatment of erectile dysfunction (2008) · cites this paper as Conaglen and Conaglen 2008
In the citing paper
“The female partners reported more relaxed, more satisfying, and longer-lasting sexual experiences with tadalafil as compared with sildenafil (Conaglen and Conaglen 2008).”
From Tadalafil in the treatment of erectile dysfunction (2008) · cites this paper as Conaglen and Conaglen 2008
In the citing paper
“The Partner’s Preference Study was a randomized, crossover study from a single center comparing tadalafil and sildenafil in 100 couples with the male partner having ED (Conaglen and Conaglen 2008).”
From Tadalafil in the treatment of erectile dysfunction (2008) · cites this paper as Conaglen and Conaglen 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fisher, W. A., Rosen, R. C., Eardley, I., Sand, M., & Goldstein, I. (2005) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2005.00118.x · Cited by 335
Impact of erectile dysfunction on quality of life: patient and partner perspectives
Wagner, G., Fugl-Meyer, K., & Fugl-Meyer, A. (2000) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900594 · Cited by 118
Rosen, R., Janssen, E., Wiegel, M., Bancroft, J., Althof, S., Wincze, J., Segraves, R. T., & Barlow, D. (2006) · Journal of Sex & Marital Therapy · doi:10.1080/00926230600575314 · Cited by 43
Research works printed but not linked: 21
- Fugl-Meyer, 1997, On life satisfaction in male erectile dysfunction, Int J Impot Res, 9, 141, 10.1038/sj.ijir.3900269 · DOI · Paper page
- Althof, 2006, Self-esteem, confidence, and relationships in men treated with sildenafil citrate for erectile dysfunction, J Gen Intern Med, 21, 1069, 10.1111/j.1525-1497.2006.00554.x · DOI
- Cameron, 2005, Sexual and relationship characteristics among an internet-based sample of US men with and without erectile dysfunction, J Sex Marital Ther, 31, 229, 10.1080/00926230590513447 · DOI
- Matic, 2007, Relationship functioning, quality of life and masculinity among men with erectile dysfunction, Int J Impot Res, 19, 418, 10.1038/sj.ijir.3901566 · DOI
- Lowy, 2007, Quality of erection questionnaire correlates: Change in erection quality with erectile function, hardness, and psychosocial measures in men treated with sildenafil for erectile dysfunction, J Sex Med, 4, 83, 10.1111/j.1743-6109.2006.00398.x · DOI
- Govier, 2003, A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction, Clin Ther, 25, 2709, 10.1016/S0149-2918(03)80328-4 · DOI · Paper page
- Ströberg, 2003, Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: Results of a European multicenter, open-label study of patient preference, Clin Ther, 25, 2724, 10.1016/S0149-2918(03)80329-6 · DOI · Paper page
- Eardley, 2005, An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naive to phosphodiesterase 5 inhibitor therapy, BJU Int, 96, 1323, 10.1111/j.1464-410X.2005.05892.x · DOI
- Dean, 2006, Psychosocial outcomes and drug attributes affecting treatment choice in men receiving sildenafil citrate and tadalafil for the treatment of erectile dysfunction: Results of a multi-center, randomized, open-label, crossover study, J Sex Med, 3, 650, 10.1111/j.1743-6109.2006.00261.x · DOI
- Eardley, 2007, Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: Post hoc analysis of data from a multicentre, randomized, open-label, crossover study, BJU Int, 100, 122, 10.1111/j.1464-410X.2007.06916.x · DOI
- Riley, 2002, The role of the partner in erectile dysfunction and its treatment, Int J Impot Res, 14, S105, 10.1038/sj.ijir.3900800 · DOI
- Colson, 2005, Women faced with the problem of erectile dysfunction: Women's view on a male problem, Prog Urol, 15, 710
- Boisaubin, 2004, Prescribing, J Med Philos, 29, 739, 10.1080/03605310490883055 · DOI
- Althof, 2006, Through the eyes of women: The partners' perspective on tadalafil, J Urol, 68, 631, 10.1016/j.urology.2006.03.054 · DOI
- Tomlinson, 2004, Impact of erectile dysfunction and its subsequent treatment with sildenafil: Qualitative study, BMJ, 328, 1037, 10.1136/bmj.38044.662176.EE · DOI · Paper page
- Edwards, 2006, Vardenafil improves sexual function and treatment satisfaction in couples affected by erectile dysfunction (ED): A randomized double-blind, placebo-controlled trial in PDE5 inhibitor-naive men with ED and their partners, J Sex Med, 3, 1028, 10.1111/j.1743-6109.2006.00329.x · DOI
- Lee, 2006, Physician-rated patient preference and patient- and partner-rated preference for tadalafil or sildenafil citrate: Results from the Canadian “Treatment of Erectile Dysfunction” observational study, BJU Int, 98, 623, 10.1111/j.1464-410X.2006.06384.x · DOI
- Rosen, 2006, Research instruments for the diagnosis and treatment of patients with erectile dysfunction, Urology, 68, 6, 10.1016/j.urology.2006.05.046 · DOI
- Mulhall, 2006, Erection hardness: A unifying factor for defining response in the treatment of erectile dysfunction, Urology, 68, 17, 10.1016/j.urology.2006.05.041 · DOI
- Mulhall, 2006, Evaluating preference trials of oral phosphodiesterase 5 inhibitors for erectile dysfunction, Eur Urol, 49, 30, 10.1016/j.eururo.2005.09.001 · DOI
- Ströberg, 2007, Is sex only for the healthy and wealthy?, J Sex Med, 4, 176, 10.1111/j.1743-6109.2006.00233.x · DOI
Cited by
Psychological and interpersonal dimensions of sexual function and dysfunction
Brotto, L., Atallah, S., Johnson-Agbakwu, C., Rosenbaum, T., Abdo, C., Byers, E. S., Graham, C., Nobre, P., & Wylie, K. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.01.019 · Cited by 439
Yuan, J., Zhang, R., Yang, Z., Lee, J., Liu, Y., Tian, J., Qin, X., Ren, Z., Ding, H., Chen, Q., et al. (2013) · European Urology · doi:10.1016/j.eururo.2013.01.012 · Cited by 260
Tadalafil in the treatment of erectile dysfunction
Coward, R., & Carson, C. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3336 · Cited by 138
Fisher, W. A., Eardley, I., McCabe, M., & Sand, M. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01432.x · Cited by 74
The role of the sexual partner in managing erectile dysfunction
Li, H., Gao, T., & Wang, R. (2016) · Nature Reviews Urology · doi:10.1038/nrurol.2015.315 · Cited by 65
Metadata
- Authors
- Conaglen, H. M., & Conaglen, J. V.
- Affiliations
- University of Waikato—Psychology , Hamilton , New Zealand
- University of Auckland—Faculty of Medical and Health Sciences , Hamilton , New Zealand
- Venue
- The Journal of Sexual Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-05-01
- Volume
- 5
- Issue
- 5
- Pages
- 1198-1207
- ISSN
- 1743-6109
- 1743-6095
- Cited by
- 39
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
